BIOMAT Database Logo BIOMAT Database Logo

Synthesis of carbocyclic nucleosides bearing a cyclopropane ring. 1999

Y Yamatoya, and M Ishikura, and N Katagiri
Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

A carbocyclic cyclopropane fused nucleoside, 9-(c-4-hydroxymethylbicyclo[3.1.0]hex-r-2-yl)-9H-adenine, has been efficiently synthesized from 2-azabicyclo-[2.2.1]hex-5-en-3-one (ABH) in 6 steps, namely cyclopropanation, -reductive amide cleavage (RAC) reaction and adenine ring construction.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Y Yamatoya, and M Ishikura, and N Katagiri
Synthesis of bicyclo[3.1.0]hexanes functionalized at the tip of the cyclopropane ring. Application to the synthesis of carbocyclic nucleosides.
February 2006, Organic letters,
Y Yamatoya, and M Ishikura, and N Katagiri
[Synthesis of novel nucleosides: carbocyclic nucleosides].
July 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Y Yamatoya, and M Ishikura, and N Katagiri
Ribonucleoside transformations. Synthesis of purine and pyrimidine nucleosides containing a fused cyclopropane ring.
January 1991, Nucleic acids symposium series,
Y Yamatoya, and M Ishikura, and N Katagiri
Novel carbocyclic nucleosides containing a cyclobutyl ring: adenosine analogues.
September 2001, Chemical & pharmaceutical bulletin,
Y Yamatoya, and M Ishikura, and N Katagiri
Solid-phase synthesis of carbocyclic nucleosides.
April 2000, Organic letters,
Y Yamatoya, and M Ishikura, and N Katagiri
Diastereoselective Flexible Synthesis of Carbocyclic C-Nucleosides.
April 2017, The Journal of organic chemistry,
Y Yamatoya, and M Ishikura, and N Katagiri
Catalytic asymmetric synthesis of carbocyclic C-nucleosides.
January 2022, Communications chemistry,
Y Yamatoya, and M Ishikura, and N Katagiri
Synthesis of carbocyclic purine nucleosides using key intermediates, carbocyclic AICA-ribosides.
January 1987, Nucleic acids symposium series,
Y Yamatoya, and M Ishikura, and N Katagiri
Synthesis of novel carbocyclic nucleosides with a modified cyclopentane ring and evaluation of their antiviral activity.
January 1999, Nucleosides & nucleotides,
Y Yamatoya, and M Ishikura, and N Katagiri
Carbocyclic nucleosides.
January 1986, Medicinal research reviews,
Copied contents to your clipboard!